CLINICAL CHARACTERISTICS OF PATIENTS WITH SEASONAL ALLERGIC RHINOCONJUNCTIVITIS (SARK). ANAMNESTIC DATA AND THE STRUCTURE OF COMORBIDITY

Олексій Кузнєцов
{"title":"CLINICAL CHARACTERISTICS OF PATIENTS WITH SEASONAL ALLERGIC RHINOCONJUNCTIVITIS (SARK). ANAMNESTIC DATA AND THE STRUCTURE OF COMORBIDITY","authors":"Олексій Кузнєцов","doi":"10.37321/immunology.2020.02-08","DOIUrl":null,"url":null,"abstract":"Introduction. Seasonal allergic rhinitis is AZ of mucous membranes (primarily the conjunctiva of the eye and nasal mucosa), due to hypersensitivity to aerosol allergens of plant pollen and fungi spores, the concentration of which in the air periodically becomes prijenosnog. The leading clinical manifestation of SAR is considered as allergic conjunctivitis. According to statistics, about 70-90% of patients with SAR develops Pulawy conjunctivitis, characterized by itching of eyes, eyelids, their redness, photophobia, lacrimation. Clinically important is the combination of SAR and conjunctivitis. Although the SAR attention usually emphasize on nasal symptoms, more than 80% of patients, as practice shows, suffer from symptoms from the eyes. According to the European and North American researchers, more than 70% of patients with SAR suffer from eye and nasal symptoms, and their severity the majority of patients assessed asmoderate or severe.Materials and methods. Clinical and anamnestic study was done in 120 patients aged from 19 to 45 years. All the studied patients were divided according to the degree of severity of the disease: 58 patients with moderate course of seasonal allergic rhinitis and conjunctivitis (EYE), which caused Pilica ambrosia and 62 patients with severe SARK, which pilca caused by ragweed. Of these, 43 (35,8%) women, 77 (64.1%) of men aged 19 to 25 years – 76 (63.3 per cent), from 25 to 45 years – 44 (36.6%) patients. The control group consisted of 30 healthy people.Research results. The differentiation of the history of infectious diseases patients. In the studied patients SARK with moderate current, acute respiratory illness (ARI) was observed in 54 (26,9%) patients, varicella – 16 (8,0%), mumps – 12 (6,0%), measles in 11 (5,5%), viral hepatitis in 4 (1,9%) patients, acute bronchitis 36 (17,9%), pneumonia – 17 (8,5%), the scarlet fever in 6 (2.9%) and intestinal infection in 7 (3,5%), sore throat – 25 (12,4%), otitis in 13 (6,5%) patients. In patients with severe SARK, ARI was observed in 59 (23,3%) patients, varicella – 24 (9,5%), mumps – in 18 (7.1 percent), measles – in 16 (6.3 percent), viral hepatitis in 7 (2.8%) and acute bronchitis – in 43 (17%), pneumonia in 19 (7,5%), scarlet fever in 8 (3,2%), intestinal infection in 9 (3,6%), angina 32 (12,6%), otitis media – in 18 (7.1 per cent) patients.Analyzing the structure of infectious diseases in the anamnesis in the studied patients SARK need to emphasize that their structure is dominated infection in the upper respiratory tract and broncho-pulmonary system that leads to depletion of nonspecific and specific immunity factors, formation of secondary immunodeficiency in these systems.Discussion of research. In the study of biochemical parameters of blood in patients with SARK in the period of aggravation established that the greatest changes are observed from endogenous cholesterol and phospholipids, which may indicate the failure of the macrophage link of immunity. At the same time, β-lipoproteins and NIK was increased only in the group of patients with severe SARK. The increase of phospholipids in serum of patients with severe SARK can point to the implementation of late phase allergic inflammation in cellular tissue structure of the nasal mucosa.Conclusions. Conducted research of history data, the structure of comorbidity, laboratory parameters allergological studies have shown that SARK is formed on the background of progressive sensitization and allergization of the organism, which is implemented in the manifestation of allergic reactions, forming the severity of SARK, and on the strength of the immune response to a variety of ecoalign that define the types of immunopathological reactions in this cohort of patients.","PeriodicalId":245566,"journal":{"name":"Immunology and Allergy: Science and Practice","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunology and Allergy: Science and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37321/immunology.2020.02-08","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction. Seasonal allergic rhinitis is AZ of mucous membranes (primarily the conjunctiva of the eye and nasal mucosa), due to hypersensitivity to aerosol allergens of plant pollen and fungi spores, the concentration of which in the air periodically becomes prijenosnog. The leading clinical manifestation of SAR is considered as allergic conjunctivitis. According to statistics, about 70-90% of patients with SAR develops Pulawy conjunctivitis, characterized by itching of eyes, eyelids, their redness, photophobia, lacrimation. Clinically important is the combination of SAR and conjunctivitis. Although the SAR attention usually emphasize on nasal symptoms, more than 80% of patients, as practice shows, suffer from symptoms from the eyes. According to the European and North American researchers, more than 70% of patients with SAR suffer from eye and nasal symptoms, and their severity the majority of patients assessed asmoderate or severe.Materials and methods. Clinical and anamnestic study was done in 120 patients aged from 19 to 45 years. All the studied patients were divided according to the degree of severity of the disease: 58 patients with moderate course of seasonal allergic rhinitis and conjunctivitis (EYE), which caused Pilica ambrosia and 62 patients with severe SARK, which pilca caused by ragweed. Of these, 43 (35,8%) women, 77 (64.1%) of men aged 19 to 25 years – 76 (63.3 per cent), from 25 to 45 years – 44 (36.6%) patients. The control group consisted of 30 healthy people.Research results. The differentiation of the history of infectious diseases patients. In the studied patients SARK with moderate current, acute respiratory illness (ARI) was observed in 54 (26,9%) patients, varicella – 16 (8,0%), mumps – 12 (6,0%), measles in 11 (5,5%), viral hepatitis in 4 (1,9%) patients, acute bronchitis 36 (17,9%), pneumonia – 17 (8,5%), the scarlet fever in 6 (2.9%) and intestinal infection in 7 (3,5%), sore throat – 25 (12,4%), otitis in 13 (6,5%) patients. In patients with severe SARK, ARI was observed in 59 (23,3%) patients, varicella – 24 (9,5%), mumps – in 18 (7.1 percent), measles – in 16 (6.3 percent), viral hepatitis in 7 (2.8%) and acute bronchitis – in 43 (17%), pneumonia in 19 (7,5%), scarlet fever in 8 (3,2%), intestinal infection in 9 (3,6%), angina 32 (12,6%), otitis media – in 18 (7.1 per cent) patients.Analyzing the structure of infectious diseases in the anamnesis in the studied patients SARK need to emphasize that their structure is dominated infection in the upper respiratory tract and broncho-pulmonary system that leads to depletion of nonspecific and specific immunity factors, formation of secondary immunodeficiency in these systems.Discussion of research. In the study of biochemical parameters of blood in patients with SARK in the period of aggravation established that the greatest changes are observed from endogenous cholesterol and phospholipids, which may indicate the failure of the macrophage link of immunity. At the same time, β-lipoproteins and NIK was increased only in the group of patients with severe SARK. The increase of phospholipids in serum of patients with severe SARK can point to the implementation of late phase allergic inflammation in cellular tissue structure of the nasal mucosa.Conclusions. Conducted research of history data, the structure of comorbidity, laboratory parameters allergological studies have shown that SARK is formed on the background of progressive sensitization and allergization of the organism, which is implemented in the manifestation of allergic reactions, forming the severity of SARK, and on the strength of the immune response to a variety of ecoalign that define the types of immunopathological reactions in this cohort of patients.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
季节性变应性鼻结膜炎(sark)患者的临床特点。记忆数据与合并症结构
介绍。季节性变应性鼻炎是由于对植物花粉和真菌孢子等气溶胶过敏原的超敏反应引起的粘膜(主要是眼结膜和鼻粘膜)的AZ,其在空气中的浓度周期性地变得高。SAR的主要临床表现被认为是过敏性结膜炎。据统计,约70-90%的SAR患者发展为普拉维结膜炎,其特征是眼睛、眼睑瘙痒、发红、畏光、流泪。临床上重要的是SAR合并结膜炎。尽管对SAR的关注通常侧重于鼻腔症状,但实践表明,超过80%的患者会出现眼部症状。根据欧洲和北美的研究人员的研究,超过70%的SAR患者患有眼部和鼻腔症状,其严重程度大多数患者被评估为中度或重度。材料和方法。对120例19 ~ 45岁的患者进行了临床和记忆研究。所有研究的患者根据病情严重程度分为:中度季节性变应性鼻炎和结膜炎(EYE)患者58例,其中眼部为引起鹅毛毛症,重度SARK患者62例,其中豚草引起鹅毛毛症。其中,女性43例(35.8%),男性77例(64.1%),年龄在19 - 25岁之间76例(63.3%),25 - 45岁之间44例(36.6%)。对照组由30名健康人组成。研究的结果。传染病患者病史的辨析。在研究的中等流速SARK患者中,急性呼吸道疾病(ARI) 54例(26.9%),水痘16例(8.0%),腮腺炎12例(6.0%),麻疹11例(5.5%),病毒性肝炎4例(1.9%),急性支气管炎36例(17.9%),肺炎17例(8.5%),猩红热6例(2.9%),肠道感染7例(3.5%),喉咙痛25例(12.4%),中耳炎13例(6.5%)。在严重SARK患者中,急性呼吸道感染59例(23.3%),水痘24例(9.5%),腮腺炎18例(7.1%),麻疹16例(6.3%),病毒性肝炎7例(2.8%),急性支气管炎43例(17%),肺炎19例(7.5%),猩红热8例(3.2%),肠道感染9例(3.6%),心绞痛32例(12.6%),中耳炎18例(7.1%)。分析所研究的SARK患者记忆性传染病的结构需要强调,其结构以上呼吸道和支气管肺系统感染为主,导致非特异性和特异性免疫因子耗竭,在这些系统形成继发性免疫缺陷。研究讨论。在对SARK加重期患者血液生化参数的研究中发现,内源性胆固醇和磷脂变化最大,这可能提示免疫巨噬细胞环节的失效。同时,β-脂蛋白和NIK仅在重度SARK患者组升高。重度SARK患者血清磷脂升高,提示鼻腔黏膜细胞组织结构发生了晚期变应性炎症。通过对病史资料、合并症结构、实验室参数的研究,过敏学研究表明,SARK是在机体逐渐致敏和变应性的背景下形成的,变应性是在过敏反应的表现中实现的,形成了SARK的严重程度,并在免疫应答的强度上定义了该队列患者的免疫病理反应类型。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
АСПЕКТИ МОДИФІКАЦІЇ фармакотерапії СЕЗОННОГО АЛЕРГІЧНОГО РИНІТУ THE PROGNOSIS OF INTRAUTERINE GROWTH RETARDATION OF FETUS AT DIFFERENT TERMS OF PREGNANCY IN THE CASE OF MICROELEMENTOSIS ВПЛИВ СЕКРЕТОМ КЛІТИН НА РЕГЕНЕРАТИВНИЙ ПРОЦЕС ПРИ ШКІРНО-М’ЯЗОВОМУ ПОШКОДЖЕННІ У ЩУРІВ STEM CELLS AND THEIR PARACRINE FACTORS APPROACH TO THE TREATMENT AND PREVENTION OF COVID-19: VIRUS-SPECIFIC NUTRICEUTICS AND PLANT EXTRACTS
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1